Cargando…
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer.
This clinical study reports that blood levels of the pro-inflammatory mediator platelet-activating factor (PAF) did not change in colorectal cancer patients. In contrast, plasma levels of two enzymatic activities, one implicated in PAF production (i.e. phospholipase A2) and one in PAF degradation (i...
Autores principales: | Denizot, Yves, Truffinet, Véronique, Bouvier, Stéphane, Gainant, Alain, Cubertafond, Pierre, Mathonnet, Muriel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781534/ https://www.ncbi.nlm.nih.gov/pubmed/15203567 http://dx.doi.org/10.1080/09629350410001664824 |
Ejemplares similares
-
Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome.
por: Trimoreau, F, et al.
Publicado: (2000) -
Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases
por: Vergne, P., et al.
Publicado: (1997) -
Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease(*)
por: Samsamshariat, Saedziaaldin, et al.
Publicado: (2011) -
Platelets and platelet-activating factor acetylhydrolase in septic patients
por: Ruβwurm, S, et al.
Publicado: (1999) -
Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B
por: Feng, Limin, et al.
Publicado: (2014)